Susquehanna International Group’s GT Biopharma GTBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,105
| Closed | -$23.1K | – | 6441 |
|
|
2024
Q3 | $23.1K | Sell |
10,105
-8,879
| -47% | -$20.3K | ﹤0.01% | 5387 |
|
|
2024
Q2 | $53.7K | Buy |
+18,984
| New | +$53.7K | ﹤0.01% | 5262 |
|
|
2023
Q4 | – | Sell |
-465
| Closed | -$3.36K | – | 6213 |
|
|
2023
Q3 | $3.36K | Sell |
465
-243
| -34% | -$1.76K | ﹤0.01% | 5409 |
|
|
2023
Q2 | $6.63K | Buy |
+708
| New | +$6.63K | ﹤0.01% | 5472 |
|
|
2023
Q1 | – | Sell |
-438
| Closed | -$11.8K | – | 6283 |
|
|
2022
Q4 | $11.8K | Buy |
+438
| New | +$11.8K | ﹤0.01% | 5456 |
|
|
2022
Q3 | – | Sell |
-1,484
| Closed | -$133K | – | 6438 |
|
|
2022
Q2 | $133K | Buy |
1,484
+856
| +136% | +$76.7K | ﹤0.01% | 4851 |
|
|
2022
Q1 | $54K | Sell |
628
-1,231
| -66% | -$106K | ﹤0.01% | 5300 |
|
|
2021
Q4 | $170K | Buy |
1,859
+316
| +20% | +$28.9K | ﹤0.01% | 5049 |
|
|
2021
Q3 | $312K | Buy |
+1,543
| New | +$312K | ﹤0.01% | 4258 |
|